HP
AMAG

Hikari Power’s AMAG Pharmaceuticals AMAG Stock Holding History

Hikari Power’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-43,691
Closed -$880K – 144
2018
Q1 		$880K Sell
43,691
-36,309
-45% -$614K 0.1% 65
2017
Q4 		$1.06M Buy
80,000
+10,000
+14% +$151K 0.13% 59
2017
Q3 		$1.29M Hold
70,000
– – 0.17% 55
2017
Q2 		$1.29M Buy
70,000
+30,000
+75% +$594K 0.17% 50
2017
Q1 		$902K Buy
+40,000
New +$958K 0.13% 50

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hikari Power's AMAG Position: Q2 2018 in Review

Hikari Power sold out of AMAG Pharmaceuticals (AMAG) in Q2 2018, closing a stake of 43,691 shares — an estimated $880K sold.

Hikari Power first reported a position in AMAG in Q1 2017 and held it in 5 quarters. The position peaked at $1.29M in Q3 2017. 173 funds tracked by Wall St. Rank hold AMAG as of Q2 2018.

  • Hikari Power reported no remaining AMAG Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Hikari Power sold 43,691 AMAG Pharmaceuticals shares in Q2 2018, an estimated $880K.
  • Hikari Power first reported a position in AMAG Pharmaceuticals in Q1 2017 and held it in 5 quarters.
  • Hikari Power's AMAG Pharmaceuticals position peaked at $1.29M in Q3 2017.
  • 173 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2018.

Based on Hikari Power's 13F filing for Q2 2018, filed 2 Aug 2018.